ghk-cu structure image GHK‑Cu Copper Peptide Research Solution Connection Size and Type: 2" NPT Vitamin B1,B6,B12 Injection (Bion-12 Size:25 grams

ghk-cu structure image GHK‑Cu Copper Peptide Research Solution Connection Size and Type: 2" NPT Vitamin B1,B6,B12 Injection (Bion-12 Size:25 grams

Vitamin B1,B6,B12 Injection (Bion-12 Plus) – Morvel Veterinary

The authors also noted the critical limitation: no human data exists to confirm whether these effects translate to clinical outcomes in people

Connection Size and Type: 2" NPT

Size:25 grams

ASACOL ® MR 400MG TABLETS Treatment of mild to moderate ulcerative colitis, acute attack ▶ BY MOUTH Child 12–17 years: 800 mg 3 times a day Adult: 2.4 g daily in divided doses Maintenance of remission of ulcerative colitis and Crohn’s ileo-colitis ▶ ▶ ▶ BY MOUTH ▶ ▶ Child 12–17 years: 400–800 mg 2–3 times a day Adult: 1.2–2.4 g daily in divided doses ASACOL ® MR 800MG TABLETS Treatment of mild to moderate ulcerative colitis, acute attack ▶ BY MOUTH ▶ Adult: 2.4–4.8 g daily in divided doses (Books-Courses-Medical Applications) continued → 1 Gastro-intestinal system BNF 85 1 Maintenance of remission of ulcerative colitis Gastro-intestinal system 42 Chronic bowel disorders ▶ ▶ BY MOUTH Adult: Up to 2.4 g once daily, alternatively up to 2.4 g daily in divided doses Maintenance of remission of Crohn’s ileo-colitis ▶ BY MOUTH ▶ Adult: Up to 2.4 g daily in divided doses ASACOL ® FOAM ENEMA Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectosigmoid region ▶ BY RECTUM Adult: 1 g daily for 4–6 weeks, to be administered into the rectum Treatment of acute attack of mild to moderate ulcerative colitis, affecting the descending colon ▶ BNF 85 PENTASA ® RETENTION ENEMA Treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission ▶ BY RECTUM Adult: 1 g once daily, dose to be administered at bedtime Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectosigmoid region ▶ ▶ BY RECTUM ▶ Child 12–17 years: 1 g once daily, dose to be administered at bedtime PENTASA ® SUPPOSITORIES Treatment of acute attack, ulcerative proctitis ▶ BY RECTUM ▶ BY RECTUM ▶ Adult: 1 g daily for 2–4 weeks Maintenance, ulcerative proctitis ▶ ▶ BY RECTUM Adult: 2 g once daily for 4–6 weeks, to be administered into the rectum ▶ Adult: 1 g daily ASACOL ® SUPPOSITORIES Treatment of acute attack of mild to moderate ulcerative colitis and maintenance of remission PENTASA ® TABLETS Treatment of mild to moderate ulcerative colitis, acute attack ▶ BY RECTUM ▶ BY MOUTH ▶ ▶ Adult: 0.75–1.5 g daily in divided doses, last dose to be administered at bedtime MEZAVANT ® XL Treatment of mild to moderate ulcerative colitis, acute attack ▶ BY MOUTH Adult: 2.4 g once daily, increased if necessary to 4.8 g once daily, review treatment at 8 weeks Maintenance of remission of ulcerative colitis ▶ ▶ BY MOUTH ▶ Adult: 2.4 g once daily Adult: Up to 4 g once daily, alternatively up to 4 g daily in 2–3 divided doses Maintenance of remission of ulcerative colitis ▶ BY MOUTH ▶ Adult: 2 g once daily SALOFALK ® ENEMA Treatment of acute attack of mild to moderate ulcerative colitis or maintenance of remission ▶ BY RECTUM ▶ Adult: 2 g once daily, dose to be administered at bedtime OCTASA ® Treatment of mild to moderate ulcerative colitis, acute attack SALOFALK ® GRANULES Treatment of mild to moderate ulcerative colitis, acute attack ▶ BY MOUTH ▶ BY MOUTH Adult: 2.4–4.8 g once daily, alternatively 2.4–4.8 g daily in divided doses, dose over 2.4 g daily in divided doses only Maintenance of remission of ulcerative colitis and Crohn’s ileo-colitis ▶ ▶ BY MOUTH ▶ Adult: 1.2–2.4 g once daily, alternatively daily in divided doses PENTASA ® GRANULES Treatment of mild to moderate ulcerative colitis, acute attack Child 5–17 years (body-weight up to 40 kg): 30–50 mg/kg once daily, dose preferably given in the morning, alternatively 10–20 mg/kg 3 times a day ▶ Child 5–17 years (body-weight 40 kg and above): 1.5–3 g once daily, dose preferably given in the morning, alternatively 0.5–1 g 3 times a day ▶ Adult: 1.5–3 g once daily, dose preferably taken in the morning, alternatively 0.5–1 g 3 times a day Maintenance of remission of ulcerative colitis ▶ ▶ BY MOUTH ▶ ▶ BY MOUTH Child 5–17 years (body-weight up to 40 kg): 10–20 mg/kg 3 times a day ▶ Child 5–17 years (body-weight 40 kg and above): 1–2 g twice daily, total daily dose may alternatively be given in 3–4 divided doses ▶ Adult: Up to 4 g once daily, alternatively up to 4 g daily in 2–4 divided doses Maintenance of remission of ulcerative colitis ▶ ▶ BY MOUTH ▶ ▶ ▶ ▶ ▶ SALOFALK ® RECTAL FOAM Treatment of mild ulcerative colitis affecting sigmoid colon and rectum ▶ BY RECTUM ▶ Child 5–17 years (body-weight up to 40 kg): 7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses Child 5–17 years (body-weight 40 kg and above): 2 g once daily Adult: 2 g once daily Child 5–17 years (body-weight up to 40 kg): 7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses Child 5–17 years (body-weight 40 kg and above): 500 mg 3 times a day Adult: 500 mg 3 times a day ▶ Child 12–17 years: 2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses Adult: 2 g once daily, dose to be administered into the rectum at bedtime, alternatively 2 g daily in 2 divided doses (Books-Courses-Medical Applications) Inflammatory bowel disease 43 SALOFALK ® SUPPOSITORIES Treatment of acute attack of mild to moderate ulcerative colitis affecting the rectum l ▶ BY RECTUM ▶ Adult: 0.5–1 g 2–3 times a day, adjusted according to response, dose to be given using 500 mg suppositories, alternatively 1 g once daily, preferably at bedtime, dose to be given using 1 g suppositories l SALOFALK ® TABLETS Treatment of mild to moderate ulcerative colitis, acute attack ▶ BY MOUTH Child 5–17 years (body-weight up to 40 kg): 10–20 mg/kg 3 times a day ▶ Child 5–17 years (body-weight 40 kg and above): 0.5–1 g 3 times a day ▶ Adult: 0.5–1 g 3 times a day Maintenance of remission of ulcerative colitis ▶ ▶ BY MOUTH ▶ ▶ ▶ l Child 5–17 years (body-weight up to 40 kg): 7.5–15 mg/kg twice daily, total daily dose may alternatively be given in 3 divided doses Child 5–17 years (body-weight 40 kg and above): 500 mg 3 times a day Adult: 500 mg 3 times a day UNLICENSED USE ® ▶ With oral use in children Asacol (all preparations) not licensed for use in children under 18 years